LyrArc Article Gist
After a disastrous drop in sales in Mexico, Spain and the US and the $15 billion Rinker acquisition, Cemex has pledged to use all cash flow to bankers till 2014 for repayment.

LyrArc Article Gist
Amazon profit was $92 million on sales of $23.18 billion for 2nd quarter 2015. Amazon shares went up by 17% with the profit announcement. By contrast Apple's results showed huge profits up 38% and improving margins, yet the stock price declined, possibly because of an expected slowdown in China sales which played a part in Apple's better results. This shows different ways analysts and investors look at tech companies. Amazon has growth of close to 20% for several years, with large investments in warehouses to speed shipping, and early investments in cloud computing. Amazon made operating profits of $703 million on sales increase of 25% to $13.8 billion for the 2nd quarter 2015 in the North American market. Overseas sales increased only by 3% to $7.6 billion showing operating loss of $19 million. Amazon plans to expand with a consumer retail site for Mexico. Sales growth in North America and in cloud computing are two bright spots. In cloud computing services Amazon Web Services increased sales 81% to $1.82 billion, higher than 1st quarter growth of 49%. Profit for 2nd quarter in cloud computing was $391 million, compared to $77 million in the same quarter in 2014. ...

LyrArc Article Gist
Bill Gates on the impotance of giving specific feedback to teachers for improvement and the designing of a teacher evaluation system that relies on a number of factors beyond just student test scores. He says teaching is more complex than that and requires other factors such as peer group and other educator assessments based on classroom observations, student feedback, and items that reflect a focus on improved teaching skills and effectiveness in the classroom setting. Public disclosure of ratings is a bad idea says Gates, because it is not intended to embarrass teachers.

LyrArc Article Gist
The Kaplan division reported a loss of $13.2 million in the 1st quarter, because of decline in enrollments at Kaplan Higher Education and tighter government scrutiny of for-profit education and student loans.

LyrArc Article Gist
Outflows from the PIMCO Total Return Fund for the 11th consecutive month in March 2014. This fund returned a loss of 0.57% in March 2014 compared to benchmark Barclays U.S. Aggregate Bond Index loss of 0.17%, according to Morningstar.

LyrArc Article Gist
Visa Inc., MasterCard Inc. and some large banks agreed to a $6 billion settlement for a lawsuit that alleges price fixing. It provides an additional $1.2 billion fee relief for retailers. Visa will pay 67% of the settlement, MasterCard 12%, and the large banks 21%. Merchants pay about $25 billion each year to card issuing banks in interchange fees charged for each credit card transaction. Large retailers filed the lawsuits in 2005, including Kroger, Safeway, Walgreen. Other merchants including doctors and small business owners joined the lawsuits, which were later combined in the U.S. District Court of Brooklyn.

LyrArc Article Gist
Ford's European operations- which make the Fiesta and Focus models at plants in Belgium, Spain, and Germany- are suffering from the slowdown in automobile sales in Europe. Ford's European sales for vehicles sold declined by 7.3% in the first quarter of 2012. Analysts estimate a loss of $199 million in the first quarter, after a $190 million loss in the fourth quarter of 2011. This is expected to reduce global profits by 50% to $1.34 billion. Fiat Renault has responded to the economic anxiety of buyers at a time of high unemployment by appealing to cost conscious buyers with its lower cost Logan models. Ford's models appeal to middle clas buyers, which are harder to sell in countries like Spain where unemployment exceeds 20%.

LyrArc Article Gist
Takeda Pharmaceutical is negotiating the acquisition of Swiss drugmaker Nycomed for about $14 billion. Takeda has cash reserves of $10.8 billion and will be using this to fund the acquisition, as well as loans from banks. The strong yen has made acquisitions easier for Japanese companies. Takeda's Prevacid ulcer treatment and the Actos diabetes treatment have both expired. A generic launch of Actos is expected in August 2011. Takeda bought the U.S. unit of Millenium Pharmaceutical in 2008 for $8.9 billion for a significant presence in the oncology field. Takeda projects a drop in net profit by April 2013 by 35%, and sales by 11%, for the fiscal year 2013. Takeda's president says it will make investments in China of about 20-30 billon yen and target a ten fold increase in sales in China to 30 billion yen by 2015.